Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE PAYZAC : revenue, balance sheet and financial ratios

PHARMACIE DE PAYZAC is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PAYZAC (24270), this company of category PME shows in 2022 a revenue of 963 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE PAYZAC (SIREN 794385625)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 963 269 € N/C N/C N/C N/C N/C N/C
Net income 89 804 € 36 849 € 12 853 € 23 981 € 29 130 € 66 868 € 52 774 € 39 172 €
EBITDA N/C 57 530 € N/C N/C N/C N/C N/C N/C
Net margin N/C 3.8% N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, PHARMACIE DE PAYZAC generates positive net income of 90 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 39 k€ -> 90 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

89 804 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 25%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

24.708%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

68.466%

Solvency indicators evolution
PHARMACIE DE PAYZAC

Sector positioning

Debt ratio
24.71 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -13 pts over 3 years

In 2023, the debt ratio of PHARMACIE DE PAYZAC (24.71) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
68.47% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent +16 pts over 3 years

In 2023, the financial autonomy of PHARMACIE DE PAYZAC (68.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
3.81 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of PHARMACIE DE PAYZAC (3.81) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 140.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

140.984

Liquidity indicators evolution
PHARMACIE DE PAYZAC

Sector positioning

Liquidity ratio
140.98 2023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average +9 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE DE PAYZAC (140.98) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
5.82x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent

In 2022, the interest coverage of PHARMACIE DE PAYZAC (5.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DE PAYZAC

Positioning of PHARMACIE DE PAYZAC in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE DE PAYZAC is estimated at 1 059 640 € (range 644 417€ - 1 489 616€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
644k€ 1059k€ 1489k€
1 059 640 € Range: 644 417€ - 1 489 616€
NAF 5 année 2023

Valuation method used

Net Income Multiple
89 804 € × 11.8x = 1 059 640 €
Range: 644 418€ - 1 489 616€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE PAYZAC with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE PAYZAC

What is the revenue of PHARMACIE DE PAYZAC ?

The revenue of PHARMACIE DE PAYZAC in 2022 is 963 k€.

Is PHARMACIE DE PAYZAC profitable?

Yes, PHARMACIE DE PAYZAC generated a net profit of 90 k€ in 2023.

Where is the headquarters of PHARMACIE DE PAYZAC ?

The headquarters of PHARMACIE DE PAYZAC is located in PAYZAC (24270), in the department Dordogne.

Where to find the tax return of PHARMACIE DE PAYZAC ?

The tax return of PHARMACIE DE PAYZAC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE PAYZAC operate?

PHARMACIE DE PAYZAC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.